Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates

Salam Alkindi, Shoaib Al Zadjali, Ali Al Madhani, Shahina Daar, Hamood Al Haddabi, Qamariya Al Abri, David Gravell, Tsouria Berbar, Sahaya Pravin, Anil Pathare, Rajagopal Krishnamoorthy

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

To evaluate the incidence of hemoglobinopathies in Omani subjects and to forecast its future burden on health resources, we initiated a prospective neonatal screening program in two major cities of the Sultanate of Oman. Consecutive cord blood samples from a total of 7,837 neonates were analyzed for complete blood counts and for hemoglobin (Hb) profile by high performance liquid chromatography (HPLC). No case with Hb H (β4) was detected. We observed that the overall incidence of α-thalassemia (α-thal) was 48.5 [based on the presence of Hb Bart's (γ4)] and the β-globin-related abnormalities accounted for 9.5 of the samples (4.8 sickle cell trait, 2.6 β-thal trait, 0.9 Hb E trait, 0.8 Hb D trait, 0.08 Hb C trait, 0.3 sickle cell disease and 0.08 homozygous β-thal). This is also the first large study to establish reference ranges of cord red blood cell (RBC) indices for Omani neonates.

Original languageEnglish
Pages (from-to)135-144
Number of pages10
JournalHemoglobin
Volume34
Issue number2
DOIs
Publication statusPublished - Apr 2010

Fingerprint

Neonatal Screening
Hemoglobinopathies
Fetal Blood
Screening
Hemoglobin H
Blood
Hemoglobin E
Hemoglobin C
Newborn Infant
Oman
Sickle Cell Trait
Erythrocyte Indices
Thalassemia
Globins
Blood Cell Count
Health Resources
Incidence
Sickle Cell Anemia
Reference Values
Hemoglobins

Keywords

  • α-Thalassemia (α-thal)Oman
  • Neonatal screening
  • Red cell indices

ASJC Scopus subject areas

  • Hematology
  • Genetics(clinical)
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Alkindi, S., Al Zadjali, S., Al Madhani, A., Daar, S., Al Haddabi, H., Al Abri, Q., ... Krishnamoorthy, R. (2010). Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates. Hemoglobin, 34(2), 135-144. https://doi.org/10.3109/03630261003677213

Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates. / Alkindi, Salam; Al Zadjali, Shoaib; Al Madhani, Ali; Daar, Shahina; Al Haddabi, Hamood; Al Abri, Qamariya; Gravell, David; Berbar, Tsouria; Pravin, Sahaya; Pathare, Anil; Krishnamoorthy, Rajagopal.

In: Hemoglobin, Vol. 34, No. 2, 04.2010, p. 135-144.

Research output: Contribution to journalArticle

Alkindi, S, Al Zadjali, S, Al Madhani, A, Daar, S, Al Haddabi, H, Al Abri, Q, Gravell, D, Berbar, T, Pravin, S, Pathare, A & Krishnamoorthy, R 2010, 'Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates', Hemoglobin, vol. 34, no. 2, pp. 135-144. https://doi.org/10.3109/03630261003677213
Alkindi, Salam ; Al Zadjali, Shoaib ; Al Madhani, Ali ; Daar, Shahina ; Al Haddabi, Hamood ; Al Abri, Qamariya ; Gravell, David ; Berbar, Tsouria ; Pravin, Sahaya ; Pathare, Anil ; Krishnamoorthy, Rajagopal. / Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates. In: Hemoglobin. 2010 ; Vol. 34, No. 2. pp. 135-144.
@article{526df73be86b4e98beafd32edcbfb84b,
title = "Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates",
abstract = "To evaluate the incidence of hemoglobinopathies in Omani subjects and to forecast its future burden on health resources, we initiated a prospective neonatal screening program in two major cities of the Sultanate of Oman. Consecutive cord blood samples from a total of 7,837 neonates were analyzed for complete blood counts and for hemoglobin (Hb) profile by high performance liquid chromatography (HPLC). No case with Hb H (β4) was detected. We observed that the overall incidence of α-thalassemia (α-thal) was 48.5 [based on the presence of Hb Bart's (γ4)] and the β-globin-related abnormalities accounted for 9.5 of the samples (4.8 sickle cell trait, 2.6 β-thal trait, 0.9 Hb E trait, 0.8 Hb D trait, 0.08 Hb C trait, 0.3 sickle cell disease and 0.08 homozygous β-thal). This is also the first large study to establish reference ranges of cord red blood cell (RBC) indices for Omani neonates.",
keywords = "α-Thalassemia (α-thal)Oman, Neonatal screening, Red cell indices",
author = "Salam Alkindi and {Al Zadjali}, Shoaib and {Al Madhani}, Ali and Shahina Daar and {Al Haddabi}, Hamood and {Al Abri}, Qamariya and David Gravell and Tsouria Berbar and Sahaya Pravin and Anil Pathare and Rajagopal Krishnamoorthy",
year = "2010",
month = "4",
doi = "10.3109/03630261003677213",
language = "English",
volume = "34",
pages = "135--144",
journal = "Hemoglobin",
issn = "0363-0269",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates

AU - Alkindi, Salam

AU - Al Zadjali, Shoaib

AU - Al Madhani, Ali

AU - Daar, Shahina

AU - Al Haddabi, Hamood

AU - Al Abri, Qamariya

AU - Gravell, David

AU - Berbar, Tsouria

AU - Pravin, Sahaya

AU - Pathare, Anil

AU - Krishnamoorthy, Rajagopal

PY - 2010/4

Y1 - 2010/4

N2 - To evaluate the incidence of hemoglobinopathies in Omani subjects and to forecast its future burden on health resources, we initiated a prospective neonatal screening program in two major cities of the Sultanate of Oman. Consecutive cord blood samples from a total of 7,837 neonates were analyzed for complete blood counts and for hemoglobin (Hb) profile by high performance liquid chromatography (HPLC). No case with Hb H (β4) was detected. We observed that the overall incidence of α-thalassemia (α-thal) was 48.5 [based on the presence of Hb Bart's (γ4)] and the β-globin-related abnormalities accounted for 9.5 of the samples (4.8 sickle cell trait, 2.6 β-thal trait, 0.9 Hb E trait, 0.8 Hb D trait, 0.08 Hb C trait, 0.3 sickle cell disease and 0.08 homozygous β-thal). This is also the first large study to establish reference ranges of cord red blood cell (RBC) indices for Omani neonates.

AB - To evaluate the incidence of hemoglobinopathies in Omani subjects and to forecast its future burden on health resources, we initiated a prospective neonatal screening program in two major cities of the Sultanate of Oman. Consecutive cord blood samples from a total of 7,837 neonates were analyzed for complete blood counts and for hemoglobin (Hb) profile by high performance liquid chromatography (HPLC). No case with Hb H (β4) was detected. We observed that the overall incidence of α-thalassemia (α-thal) was 48.5 [based on the presence of Hb Bart's (γ4)] and the β-globin-related abnormalities accounted for 9.5 of the samples (4.8 sickle cell trait, 2.6 β-thal trait, 0.9 Hb E trait, 0.8 Hb D trait, 0.08 Hb C trait, 0.3 sickle cell disease and 0.08 homozygous β-thal). This is also the first large study to establish reference ranges of cord red blood cell (RBC) indices for Omani neonates.

KW - α-Thalassemia (α-thal)Oman

KW - Neonatal screening

KW - Red cell indices

UR - http://www.scopus.com/inward/record.url?scp=77950495950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950495950&partnerID=8YFLogxK

U2 - 10.3109/03630261003677213

DO - 10.3109/03630261003677213

M3 - Article

C2 - 20353348

AN - SCOPUS:77950495950

VL - 34

SP - 135

EP - 144

JO - Hemoglobin

JF - Hemoglobin

SN - 0363-0269

IS - 2

ER -